Related content

Importance of identification and treatment of Raynaud’’s phenomenon

By Frech Tracy   Sawitzke Allen  

Future Rheumatology, Vol. 2, Iss. 5, 2007-10 ,pp. : 521-525

Future Medicine

Access to resources Recommend Favorite

The usefulness of power Doppler ultrasonography in differentiating primary and secondary Raynaud’s phenomenon

By Lee Sang   Lee Sang   Yoo Wan  

Clinical Rheumatology, Vol. 25, Iss. 6, 2006-11 ,pp. : 814-818

Springer Publishing Company

Access to resources Recommend Favorite

Comparison between iloprost and alprostadil in the treatment of Raynaud's phenomenon

By Marasini B   Massarotti M   Bottasso B   Coppola R   Papa N Del   Maglione W   Comina DP   Maioli C  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 4, 2004-07 ,pp. : 253-257

Informa Healthcare

Access to resources Recommend Favorite

The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis

By Pauling J. D.   O’Donnell V. B.   Mchugh N. J.  

Platelets, Vol. 24, Iss. 7, 2013-11 ,pp. : 503-515

Informa Healthcare

Access to resources Recommend Favorite

Relative roles of endothelial cell damage and platelet activation in primary Raynaud's phenomenon (RP) and RP secondary to systemic sclerosis

By Silveri Ferdinando   De Angelis Rossella   Poggi Andreina   Muti Stefania   Bonapace Giuseppe   Argentati Franco   Cervini Claudio  

Scandinavian Journal of Rheumatology, Vol. 30, Iss. 5, 2001-10 ,pp. : 290-296

Informa Healthcare

Access to resources Recommend Favorite